Literature DB >> 14973405

Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.

E Carmina1.   

Abstract

In the past, the diagnosis of polycystic ovary syndrome (PCOS) was based on National Institute of Health (NIH) criteria (hyperandrogenism and chronic anovulation) or on sonographic findings of polycystic ovaries. Diffe-rences in diagnosis criteria made it difficult to compare the data of studies coming from different countries. Moreover, there was criticism of both the methods used. In 2003, at a joint meeting of the European Society for Human Reproduction (ESHRE) and the American Society of Reproductive Medicine (ASRM), new guidelines for the diagnosis of PCOS were suggested. According to these guidelines, it is possible to reach a diagnosis of PCOS when at least 2 of these 3 elements are present: hyperandrogenism, chronic anovulation and polycystic ovaries. New criteria for the echographic diagnosis of polycystic ovaries have been suggested, too. These diagnostic guidelines represent important progress because they are more flexible and permit us to make the diagnosis in patients who were previously excluded by the syndrome (such as ovulatory hyperandrogenic women with polycystic ovaries or anovulatory normoandrogenic women with polycystic ovaries). However, doubts still exist and regard some borderline group of patients such as hirsute ovulatory normoandrogenic women with polycystic ovaries. A new classification of PCOS syndrome is suggested on the basis of new guidelines.

Entities:  

Mesh:

Year:  2004        PMID: 14973405

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  29 in total

Review 1.  The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.

Authors:  Konstantinos G Michalakis; James H Segars
Journal:  Fertil Steril       Date:  2010-06-19       Impact factor: 7.329

Review 2.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 3.  Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Carly E Kelley; Ann J Brown; Anna Mae Diehl; Tracy L Setji
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.

Authors:  Yoonjung Yoonie Joo; Ky'Era Actkins; Jennifer A Pacheco; Anna O Basile; Robert Carroll; David R Crosslin; Felix Day; Joshua C Denny; Digna R Velez Edwards; Hakon Hakonarson; John B Harley; Scott J Hebbring; Kevin Ho; Gail P Jarvik; Michelle Jones; Tugce Karaderi; Frank D Mentch; Cindy Meun; Bahram Namjou; Sarah Pendergrass; Marylyn D Ritchie; Ian B Stanaway; Margrit Urbanek; Theresa L Walunas; Maureen Smith; Rex L Chisholm; Abel N Kho; Lea Davis; M Geoffrey Hayes
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 5.  Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review.

Authors:  Annie W Lin; Marla E Lujan
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

6.  Oxidative stress in non-obese women with polycystic ovarian syndrome.

Authors:  Varalakshmi Desai; Namburi Rajendra Prasad; Suchitra Musturu Manohar; Alok Sachan; Srinivasa Rao Pemmaraju Venkata Lakshmi Narasimha; Aparna Rajeshwar Rao Bitla
Journal:  J Clin Diagn Res       Date:  2014-07-20

7.  Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats.

Authors:  Heather B Patisaul; Natalie Mabrey; Heather B Adewale; Alana W Sullivan
Journal:  Reprod Toxicol       Date:  2014-09-19       Impact factor: 3.143

8.  The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.

Authors:  Abbas Ali Sangouni; Fatemeh Pakravanfar; Akram Ghadiri-Anari; Azadeh Nadjarzadeh; Hossein Fallahzadeh; Mahdieh Hosseinzadeh
Journal:  Eur J Nutr       Date:  2021-11-02       Impact factor: 5.614

9.  Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis.

Authors:  Wen Kong; Xun Niu; Tianshu Zeng; Meixia Lu; Lulu Chen
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

10.  Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine.

Authors:  Samar Musmar; Asma Afaneh; Hafsa Mo'alla
Journal:  Reprod Biol Endocrinol       Date:  2013-05-20       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.